Diderich Philippe, Bertoldo Davide, Dessen Pierre, Khan Maola M, Pizzitola Irene, Held Werner, Huelsken Joerg, Heinis Christian
Institute of Chemical Sciences and Engineering, Ecole Polytechnique Fédérale de Lausanne , CH-1015 Lausanne, Switzerland.
Swiss Institute for Experimental Cancer Research (ISREC), Ecole Polytechnique Fédérale de Lausanne , CH-1015 Lausanne, Switzerland.
ACS Chem Biol. 2016 May 20;11(5):1422-7. doi: 10.1021/acschembio.5b00963. Epub 2016 Mar 11.
Short α-helical peptides stabilized by linkages between constituent amino acids offer an attractive format for ligand development. In recent years, a range of excellent ligands based on stabilized α-helices were generated by rational design using α-helical peptides of natural proteins as templates. Herein, we developed a method to engineer chemically stabilized α-helical ligands in a combinatorial fashion. In brief, peptides containing cysteines in position i and i + 4 are genetically encoded by phage display, the cysteines are modified with chemical bridges to impose α-helical conformations, and binders are isolated by affinity selection. We applied the strategy to affinity mature an α-helical peptide binding β-catenin. We succeeded in developing ligands with Kd's as low as 5.2 nM, having >200-fold improved affinity. The strategy is generally applicable for affinity maturation of any α-helical peptide. Compared to hydrocarbon stapled peptides, the herein evolved thioether-bridged peptide ligands can be synthesized more easily, as no unnatural amino acids are required and the cyclization reaction is more efficient and yields no stereoisomers. A further advantage of the thioether-bridged peptide ligands is that they can be expressed recombinantly as fusion proteins.
通过组成氨基酸之间的连接而稳定的短α-螺旋肽为配体开发提供了一种有吸引力的形式。近年来,以天然蛋白质的α-螺旋肽为模板,通过合理设计产生了一系列基于稳定α-螺旋的优良配体。在此,我们开发了一种以组合方式工程化化学稳定的α-螺旋配体的方法。简而言之,在位置i和i + 4含有半胱氨酸的肽通过噬菌体展示进行基因编码,半胱氨酸用化学桥修饰以形成α-螺旋构象,并通过亲和选择分离结合剂。我们将该策略应用于对结合β-连环蛋白的α-螺旋肽进行亲和力成熟。我们成功开发出了解离常数低至5.2 nM的配体,亲和力提高了200倍以上。该策略普遍适用于任何α-螺旋肽的亲和力成熟。与烃钉肽相比,本文所开发的硫醚桥连肽配体合成更容易,因为不需要非天然氨基酸,环化反应更有效且不产生立体异构体。硫醚桥连肽配体的另一个优点是它们可以作为融合蛋白进行重组表达。